Endemic infectious cutaneous ulcers syndrome in the Oti Region of Ghana: Study of cutaneous leishmaniasis, yaws and Haemophilus ducreyi cutaneous ulcers.


Journal

PloS one
ISSN: 1932-6203
Titre abrégé: PLoS One
Pays: United States
ID NLM: 101285081

Informations de publication

Date de publication:
2023
Historique:
received: 16 05 2023
accepted: 11 09 2023
medline: 29 9 2023
pubmed: 27 9 2023
entrez: 27 9 2023
Statut: epublish

Résumé

A recent study detected cutaneous leishmaniasis (CL) in 31.9% of persons with skin ulcers in the Oti Region of Ghana, resulting in a need to investigate other potential causes of the unexplained skin ulcers. A community based cross-sectional study was conducted in the Oti region to investigate skin ulcers of undetermined aetiologies. To confirm a diagnosis of cutaneous leishmaniasis, Buruli ulcer, Haemophilus ducreyi ulcers, or yaws, DNA obtained from each patient skin ulcer sample was systematically subjected to polymerase chain reaction (PCR) for Leishmania spp., Mycobacterium ulcerans, Haemophilus ducreyi, and Treponema pallidum sub species pertenue. A total of 101 skin ulcer samples were obtained from 101 persons. Co-infection of more than one organism was observed in 68.3% of the samples. Forty (39.6%) participants had a positive result for Leishmania spp., 68 (67.3%) for Treponema pallidum sub. Sp. pertenue, and 74 (73.3%) for H. ducreyi. Twenty (19.8%) of the patient ulcers were simultaneously infected with Leishmania spp., Treponema pallidum sub. Sp. pertenue, and H. ducreyi. None of the patients' lesions yielded a positive result for Mycobacterium ulcerans. This study detected single and mixed occurrence of the causative organisms of CL, yaws, and H. ducreyi cutaneous ulcers in CL endemic communities of the Oti Region in Ghana. These findings emphasize the importance of integrating multiple skin diseases on a common research platform and calls for the development of a comprehensive guideline for diagnosing and treating tropical ulcers in the study areas.

Sections du résumé

BACKGROUND
A recent study detected cutaneous leishmaniasis (CL) in 31.9% of persons with skin ulcers in the Oti Region of Ghana, resulting in a need to investigate other potential causes of the unexplained skin ulcers.
METHODOLOGY/PRINCIPAL FINDINGS
A community based cross-sectional study was conducted in the Oti region to investigate skin ulcers of undetermined aetiologies. To confirm a diagnosis of cutaneous leishmaniasis, Buruli ulcer, Haemophilus ducreyi ulcers, or yaws, DNA obtained from each patient skin ulcer sample was systematically subjected to polymerase chain reaction (PCR) for Leishmania spp., Mycobacterium ulcerans, Haemophilus ducreyi, and Treponema pallidum sub species pertenue. A total of 101 skin ulcer samples were obtained from 101 persons. Co-infection of more than one organism was observed in 68.3% of the samples. Forty (39.6%) participants had a positive result for Leishmania spp., 68 (67.3%) for Treponema pallidum sub. Sp. pertenue, and 74 (73.3%) for H. ducreyi. Twenty (19.8%) of the patient ulcers were simultaneously infected with Leishmania spp., Treponema pallidum sub. Sp. pertenue, and H. ducreyi. None of the patients' lesions yielded a positive result for Mycobacterium ulcerans.
CONCLUSIONS/SIGNIFICANCE
This study detected single and mixed occurrence of the causative organisms of CL, yaws, and H. ducreyi cutaneous ulcers in CL endemic communities of the Oti Region in Ghana. These findings emphasize the importance of integrating multiple skin diseases on a common research platform and calls for the development of a comprehensive guideline for diagnosing and treating tropical ulcers in the study areas.

Identifiants

pubmed: 37756291
doi: 10.1371/journal.pone.0292034
pii: PONE-D-23-14994
pmc: PMC10529585
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

e0292034

Subventions

Organisme : World Health Organization
ID : 001
Pays : International

Informations de copyright

Copyright: © 2023 Akuffo et al. This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.

Déclaration de conflit d'intérêts

The authors have declared that no competing interests exist.

Références

mBio. 2021 Jan 12;12(1):
pubmed: 33436440
PLoS Negl Trop Dis. 2021 May 24;15(5):e0009416
pubmed: 34029326
Glob Health Action. 2011;4:
pubmed: 21765823
Lancet Microbe. 2022 Apr;3(4):e250
pubmed: 35544063
Emerg Infect Dis. 2014 Oct;20(10):1705-7
pubmed: 25271477
Trop Med Infect Dis. 2018 Sep 10;3(3):
pubmed: 30274497
PLoS Negl Trop Dis. 2018 Mar 22;12(3):e0006303
pubmed: 29566044
PLoS One. 2012;7(5):e35671
pubmed: 22693548
PLoS Negl Trop Dis. 2015 Jan 29;9(1):e0003496
pubmed: 25632942
Trans R Soc Trop Med Hyg. 2002 Apr;96 Suppl 1:S185-9
pubmed: 12055836
PLoS Negl Trop Dis. 2017 May 10;11(5):e0004958
pubmed: 28489855
Trop Med Infect Dis. 2020 Oct 06;5(4):
pubmed: 33036234
PLoS Negl Trop Dis. 2010 Mar 23;4(3):e639
pubmed: 20351787
FEMS Microbiol Lett. 2010 Mar;304(2):191-4
pubmed: 20146745
Am J Trop Med Hyg. 2006 Sep;75(3):502-4
pubmed: 16968929
Lancet Infect Dis. 2007 Sep;7(9):581-96
pubmed: 17714672
Am J Trop Med Hyg. 2015 Jan;92(1):115-7
pubmed: 25331802
Int J Parasitol. 2015 Sep;45(11):679-84
pubmed: 26099650
PLoS Negl Trop Dis. 2018 Jun 5;12(6):e0006560
pubmed: 29870529
Lancet. 2013 Mar 2;381(9868):763-73
pubmed: 23415015
Br J Dermatol. 2021 Feb;184(2):189-190
pubmed: 33544440
Int J STD AIDS. 2015 Sep;26(10):696-703
pubmed: 25193248
AACN Clin Issues. 2002 Aug;13(3):382-97
pubmed: 12151992
PLoS Negl Trop Dis. 2014 Feb 06;8(2):e2630
pubmed: 24516676
Clin Infect Dis. 2019 Jan 18;68(3):482-489
pubmed: 29917039
Lancet Glob Health. 2014 Apr;2(4):e235-41
pubmed: 25103064
PLoS Negl Trop Dis. 2016 Apr 14;10(4):e0004603
pubmed: 27078028
Diagn Microbiol Infect Dis. 2008 Mar;60(3):323-7
pubmed: 18031968
Appl Environ Microbiol. 2007 Aug;73(15):4733-40
pubmed: 17526786
Lancet Glob Health. 2018 Apr;6(4):e401-e410
pubmed: 29456191
Dermatol Clin. 2021 Jan;39(1):15-22
pubmed: 33228858
Infect Dis Poverty. 2020 Mar 12;9(1):26
pubmed: 32160927

Auteurs

Richard Adjei Akuffo (RA)

Noguchi Memorial Institute for Medical Research, University of Ghana, Accra, Ghana.

Carmen Sanchez (C)

WHO Collaborating Center for Leishmaniasis, Instituto de Salud Carlos III, CIBERINFEC, Madrid, Spain.

Ivy Amanor (I)

Noguchi Memorial Institute for Medical Research, University of Ghana, Accra, Ghana.

Jennifer Seyram Amedior (JS)

Noguchi Memorial Institute for Medical Research, University of Ghana, Accra, Ghana.

Nana Konama Kotey (NK)

Ghana Health Service, Accra, Ghana.

Francis Anto (F)

School of Public Health, University of Ghana, Accra, Ghana.

Thomas Azurago (T)

Ghana Health Service, Accra, Ghana.

Anthony Ablordey (A)

Noguchi Memorial Institute for Medical Research, University of Ghana, Accra, Ghana.

Felicia Owusu-Antwi (F)

Ghana Country Office, World Health Organization, Accra, Ghana.

Abate Beshah (A)

World Health Organization Regional Office for Africa, Brazzaville, Republic of Congo.

Yaw Ampem Amoako (YA)

Kumasi Centre for Collaborative Research, Kwame Nkrumah University of Science and Technology, Kumasi, Ghana.

Richard Odame Phillips (RO)

Kumasi Centre for Collaborative Research, Kwame Nkrumah University of Science and Technology, Kumasi, Ghana.

Michael Wilson (M)

Noguchi Memorial Institute for Medical Research, University of Ghana, Accra, Ghana.

Kingsley Asiedu (K)

Department of Control of Neglected Tropical Diseases, World Health Organization, Geneva, Switzerland.

Jose-Antonio Ruiz-Postigo (JA)

Department of Control of Neglected Tropical Diseases, World Health Organization, Geneva, Switzerland.

Javier Moreno (J)

WHO Collaborating Center for Leishmaniasis, Instituto de Salud Carlos III, CIBERINFEC, Madrid, Spain.

Mourad Mokni (M)

La Rabta Hospital Dermatology Department, Research Laboratory, Faculty of Medicine, University of al-Manar 2, Tunis, Tunisia.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH